Cancer

Article	Citations
Issue Information	389
Sharp rise in esophageal cancer and Barrett esophagus seen in middle‐aged people	246
Issue Information	196
Stopping immunotherapy after 2 years is practical in patients with advanced non–small cell lung cancer	192
MRI is more accurate than a PSMA PET/CT scan for prostate cancer diagnosis	151
Updated American Cancer Society lung cancer screening guidelines	147
Issue Information	124
	109
Cutaneous β‐HPV may predict cutaneous squamous cell carcinoma	108
Issue Information	88
New standard of care for multiple myeloma?	81
	80
Erratum to “Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation”	76
The role of relative advantage for development of sequencing‐based diagnostics for pediatric cancer in low‐ and middle‐income countries	74
New test for detecting cervical adenocarcinoma	70
	62
Accelerated approval of multiple myeloma therapies	62
Cancer‐related impairments and functional limitations among long‐term cancer survivors: Gaps and opportunities for clinical practice	60
Active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer	57
Occurrence of breast‐cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two‐arm randomized clinical trial	57
Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana	55
	54
A single‐arm, multicenter, open‐label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer	54
Let's ask the patient: Self‐reported quality‐of‐life measures help to predict kidney cancer mortality	54
Active Living After Cancer: Adaptation and evaluation of a community‐based physical activity program for minority and medically underserved breast cancer survivors	53

Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia	52
Evaluation of headache in patients with cancer	51
What are the most effective exercise, physical activity and dietary interventions to improve body composition in women diagnosed with or at high‐risk of breast cancer? A systematic review and network	50
Reply to “Empathic communication: The premise of inclusive care for historically excluded populations”	50
Impact of TAILORx on chemotherapy prescribing and 21‐gene recurrence score–guided treatment costs in a population‐based cohort of patients with breast cancer	50
Impact of African ancestry on the relationship between body mass index and survival in an early‐stage breast cancer trial (ECOG‐ACRIN E5103)	50
The economics of advanced and unresectable hepatocellular carcinoma	48
Patterns of failure in pediatric medulloblastoma and implications for hippocampal sparing	47
Understanding risk factors for cancer: What's new and how can it help reduce the cancer burden?	47
What enhanced recovery means for patients with cancer undergoing surgery	46
Epistemic equity in oncology: Opportunities to leverage patient‐centric implementation in clinical trial design	46
Top advances of the year: Cervical cancer	46
Potential of circulating tumor DNA to refine immunotherapy	46
	45
Can we avoid thoracic radiotherapy in young females with Hodgkin lymphoma?	45
Aspirin but not statins is inversely related to gastric cancer with a duration–risk effect: Results from the Stomach Cancer Pooling Project Consortium	45
Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1	45
Dietary supplement use among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study	45
Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data	44
Association of high‐dose radiotherapy with improved survival in patients with newly diagnosed low‐grade gliomas	43
What’s the reality for CDK4/6 inhibitors: Clinical trials or real‐world evidence?	43
The critical need to implement and utilize patient‐reported measures of function in cancer care delivery	41
Characteristics of clinical trials of new oncology drugs approved in China	41
International perspectives on the development, application, and evaluation of a multicancer early detection strategy	41
Smoking cessation services and shared decision‐making practices among lung cancer screening facilities: A cross‐sectional study	40
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation	40
Family characteristics and childcare patterns associated with early social functioning in cancer‐bereaved parents	40
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK‐positive advanced non–small cell lung cancer	40
Multicenter study of pediatric Epstein‐Barr virus–negative monomorphic post solid organ transplant lymphoproliferative disorders	40
A guide to large data sets for population‐based cancer research: Strengths, limitations, and pitfalls	39
Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery	39
Effect of an mHealth intervention on physical activity outcomes among young adult cancer survivors: The IMPACT randomized controlled trial	39
Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials	39
Reply to “Enhancing the role of social work in managing cancer risks among LGBTQ+ populations” and “The urgency of systematically acquiring sexual orientation and gender identity data (SOGI) to ensure	38
Midlife baseline prostate‐specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality	37
Risk scores predicting disease progression in early‐stage chronic lymphocytic leukemia: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy	37
Erratum to “Unhealthy lifestyle behaviors, overweight, and obesity among childhood cancer survivors in the Netherlands: A DCCSS LATER study”	37
Improved survival and decreased cancer deaths in young adults with cancer after passage of the Affordable Care Act Dependent Coverage Expansion	37
Association between visceral adiposity index and cancer risk in the UK Biobank cohort	37
Implantable cardioverter defibrillators in people dying with cancer: A SEER‐Medicare analysis of ICD prevalence and association with aggressive end‐of‐life care	36
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first‐line treatment for patients with melanoma in‐transit metastases	36
The Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer (CISTO) study: Lessons learned about management and patient enrollment in a large, pragmatic, patient‐centere	36
“Cancer Statistics, 2025” provides data on cancer occurrence and outcomes	35
Erratum to “Incorporation of alemtuzumab into frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study”	35
Serum of interleukin‐6 and procalcitonin as early diagnostic markers for the identification of poor hematopoietic reconstitution following allogeneic hematopoietic stem cell transplantation	35
Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies	35
Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries	34
Top advances of the year: Neoadjuvant immunotherapy in melanoma	34
Best of both worlds? Linking comprehensive and noncomprehensive cancer centers	34
Implications of omitting sentinel lymph node biopsy on adjuvant decision making for patients with small breast cancers	34

Effect of smoking reduction, cessation, and resumption on cancer risk: A nationwide cohort study	33
Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer	33
Breast cancer survival in India across 11 geographic areas under the National Cancer Registry Programme	33
Recent histone deacetylase inhibitors in cancer therapy	33
Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter study	33
Erratum to “Chimeric antigen receptor–based immunotherapy in breast cancer: Recent progress in China”	33
Keep moving to prevent cancer	32
Issue Information	32
Long‐term follow‐up of a phase 2 study of all‐trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia	32
Issue Information	32
Disparities in prostate cancer screening, diagnoses, management, and outcomes between Indigenous and non‐Indigenous men in a universal health care system	32
Issue Information	31
Cardiac remodeling after anthracycline and radiotherapy exposure in adult survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study	31
Making a case for del(1p) as a high‐risk abnormality in multiple myeloma	31
	31
Comparison of long‐term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia‐positive acute lymphoblastic leukemia: A multicente	31
Issue Information	31
Safety, efficacy, and pharmacokinetics of SH‐1028 in EGFR T790M‐positive advanced non–small cell lung cancer patients: A dose‐escalation phase 1 study	31
Seroconversion and outcomes after initial and booster COVID‐19 vaccination in adults with hematologic malignancies	31
Clinical implications of tumor‐based next‐generation sequencing in high‐grade epithelial ovarian cancer	30
Impact of baseline tumor burden on overall survival in patients with radioiodine‐refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial	30
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG‐ACRIN analysis	30
Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS‐5	30
Helping patients with cancer to understand secondary findings on genetic tests	29
A Coala‐T‐Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment	29
Improving the quality of care for patients with advanced epithelial ovarian cancer: Program components, implementation barriers, and recommendations	28
	28
Associations between geography, decision‐making style, and interest in cancer clinical trial participation	28
	28
Peripheral blood parameter abnormalities precede therapy‐related myeloid neoplasms after autologous transplantation for lymphoma	28
Effect of preoperative programmed death‐1 or programmed death ligand‐1 immune check point inhibition on complications after surgery for primary head and neck cancer	28
Lost in the shadow of giants: The neglected treatment modalities in oncologic trials	27
Avelumab treatment for patients with metastatic Merkel cell carcinoma can be safely stopped after 1 year and a PET/CT–confirmed complete response	27
Landscape and clinical impact of NOTCH mutations in newly diagnosed acute myeloid leukemia	27
Cervical cancer elimination in Indian context: Moving from barriers to facilitators	27
Impact of the COVID‐19 pandemic on pediatric oncology providers globally: A mixed‐methods study	27
Immune check point inhibitors in advanced cutaneous squamous cell carcinomas: “Repeat and replicate”	27
The American Cancer Society National Lung Cancer Roundtable strategic plan: Introduction	27
Young adult males have worse survival than females that is largely independent of treatment received for many types of central nervous system tumors: A National Cancer Database analysis	26
	26
Select cases might get a benefit from chemotherapy for Stage I pT1aN0M0 HER2+ breast cancer	26
The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance	26
A phase 1 study of triple‐targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF‐mutated cancers	26
Beyond the PSA: The hidden costs of screening in prostate cancer	26
Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma	26
A randomized prospective trial of an ostomy telehealth intervention for cancer survivors	26
The use of national datasets to evaluate outcomes for invasive lobular carcinoma	26
Continuity and coordination of care for childhood cancer survivors with multiple chronic conditions: Results from the Childhood Cancer Survivor Study	26
Association between treatment‐emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study	25
Sex disparities in the incidence of 21 cancer types: Quantification of the contribution of risk factors	25
Single‐agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM‐2 trial	25
Racial inequities in the quality of surgical care among Medicare beneficiaries with localized prostate cancer	25
The protective role of postoperative radiation therapy in low and intermediate grade major salivary gland malignancies: A study of the Canadian Head and Neck Collaborative Research Initiative	25
Increased health‐related quality of life impairments of male and female survivors of childhood cancer: DCCSS LATER 2 psycho‐oncology study	25
Fecal microbiota transplantation for immunotherapy‐resistant urological tumors: Is it time? An update of the recent literature	25
Quality of life, psychological distress, and prognostic perceptions in patients with multiple myeloma	25
Olaparib in treatment‐refractory isocitrate dehydrogenase 1 (IDH1)– and IDH2‐mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 tri	24
Prevalence and determinants of metabolic syndrome in 2338 childhood cancer survivors: A Dutch Childhood Cancer Survivor LATER 2 study	24
Anti‐Müllerian hormone for assessing ovarian toxicity of cancer treatment in young women: It’s complicated	24
Estimating oncologist variability in prescribing systemic cancer therapies to patients in the last 30 days of life	24
Utilization and perceptions of chaplaincy among hospitalized adults of Dharmic religions with cancer	24
From childhood cancer to metabolic syndrome	24
Is it time for bone marrow sparing radiation therapy to be standard of care in cervical cancer?	24
Correlation analysis of invasive disease‐free survival and overall survival in a real‐world population of patients with HR+/HER2– early breast cancer	23
Anlotinib in combination with docetaxel for advanced nonsmall cell lung cancer after failure of platinum‐based treatment: A phase 1/2 trial	23
Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease	23
Real‐world treatment patterns and outcomes with oral azacitidine maintenance therapy in patients with acute myeloid leukemia	23
Standard of care for children with newly diagnosed B‐cell ALL	23
Associations between experiences of discrimination and quality of life in Black breast cancer survivors	23
Association of mental health treatment receipt with cancer screening among US adults with a history of anxiety or depression	23
Targeting ROS1 rearrangements in non–small cell lung cancer: Current insights and future directions	23
A call to action to advance patient‐focused and decentralized clinical trials	23
Impact of acupuncture and integrative therapies on chemotherapy‐induced peripheral neuropathy: A multicentered, randomized controlled trial	23
Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma	22
First person profile: Robert C. Bast Jr MD	22
Acute hospitalizations after proton therapy versus intensity‐modulated radiotherapy for locally advanced non–small cell lung cancer in the durvalumab era	22
Preclinical data suggest role of dopamine in preventing select skin cancers	22
Triple‐negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding	22
Palliative care training can help patients with advanced cancer at the end of life	22
Endoscopic balloon cryoablation plus transurethral resection for bladder cancer: A phase 2, multicenter, randomized, controlled trial	21

Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group	21
Cumulative incidence and risk factors of brain metastases in metastatic non–small cell lung cancer without baseline brain metastasis: Pooled analysis of individualized patient data from IMpower130, IM	21
Top advances of the year in colorectal cancer	21
Is repeat breast conservation possible for small ipsilateral breast cancer recurrence?	21
Lung cancer screening associated with earlier diagnosis and improved survival	21
Implementation and evaluation of a remote geriatric assessment and intervention program in Brazil	21
Hepatocellular carcinoma, vascular endothelial growth factor receptors‐targeting agents, and hypertension: A much more complicated relationship than expected	21
Reply to “Another look at floor and ceiling effects in the EORTC QLQ‐C30 Physical Functioning subscale and possible solutions”	21
Breast health equity along the cancer care continuum: A collaborative grant initiative	21
Stage I epithelial or stromal type Wilms tumors are low risk tumors: An analysis of patients treated on the SIOP‐WT‐2001 protocol in the UK‐CCLG and GPOH studies (2001–2020)	21
Targeted genotyping for recurring variants in cancer susceptibility genes in non‐Ashkenazi Jewish patients with breast cancer diagnosed ≥50 years	21
Cancer treatment in the time of COVID‐19 pandemics: A new concern	21
An editorial on a comparison of care quality metrics between Black and White men with advanced prostate cancer in the IRONMAN registry	21
Cannabis use among adults undergoing cancer treatment	20
Association between exposures to radon and γ‐ray radiation and histologic type of lung cancer in Eldorado uranium mining and milling workers from Canada	20
Top advances of the year: Targeted therapy for lung cancer	20
Association of mental health diagnosis with race and all‐cause mortality after a cancer diagnosis: Large‐scale analysis of electronic health record data	20
The impact of the COVID‐19 pandemic on African American cancer survivors	20
	20
A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas	20
Association between the amount of artificial hydration and quality of dying among terminally ill patients with cancer: The East Asian Collaborative Cross‐Cultural Study to Elucidate the Dying Process	20
Defining disease modification in myelofibrosis in the era of targeted therapy	20
Phase 1 trial of intraperitoneal paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology	19
Gaps in care highlight the need to expand access to clinical cancer trials	19
Pembrolizumab with chemoradiotherapy followed by pembrolizumab for stage III–IVa cervical cancer: is the ENGOT‐cx11/GOG‐3047/KEYNOTE‐A18 trial practice changing?	19
A prospective study on diagnostic accuracy of technology‐enabled early detection of oral cancer and epidemiology of tobacco and other substances use in rural India	19
Effects of exercise therapy on chemotherapy delivery and response in primary breast cancer: A secondary analysis of a randomized trial	19
Effects by educational attainment of a mammography screening patient decision aid for women aged 75 years and older	19
Social determinants of health and cancer mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study	19
Comparison of survival outcomes for patients with Stage III vs de novo Stage IV breast cancer	19
Glioma mutational signatures associated with haloalkane exposure are enriched in firefighters	19
AACR 2024 presents advancements in pancreatic and gastric cancers	19
Associations of serum trimethylamine N‐oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort	19
Multidimensional structural racism and estimated cancer risk from traffic‐related air pollution	19
Issue Information	19
Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study	19
Burden of female‐specific cancers in China from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021	19
Issue Information	19
CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study	19
Oncologists’ role in end‐of‐life chemotherapy and patient‐centered care	19
Assessment of the compliance, influencing factors, and yielding results of liver cancer screening in a high‐risk population: A cross‐sectional study	18
The relationship of mental health symptoms to chemotherapy toxicity risk in older adults with cancer: Results from the geriatric assessment–driven intervention study	18
CD123 expression linked to high‐risk disease in children with acute myeloid leukemia	18
Health‐related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R‐04	18
	18
	18
Cyclin‐dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple‐negative breast cancer by affecting the immune microenvironment	18
Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study	18
Erratum to “Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children’s Oncology Group”	18
Alarming recent rises in early‐onset colorectal cancer	18
Geographic diffusion of digital mammography in the United States	18
Genomics likely are not the main driver in advanced prostate cancer overall survival rate disparities	18
Systemic therapies at the end of life vary by patient and practice	18
Circulating tumor DNA‐based molecular residual disease detection for treatment monitoring in advanced melanoma patients	18
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry	18
First person profile: Fadlo R. Khuri, MD	18
Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population‐based study	18
Disparities in phase 1 cancer clinical trial enrollment	18
	18
Reasons for refusal of the human papillomavirus vaccine among young cancer survivors	18
Disease characteristics and mortality among Asian women with breast cancer	18
Parents’ and adolescents’ perspectives and understanding of information about childhood cancer precision medicine	17
Issue Information	17
Phase 1b study of pan‐AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN‐mutated advanced solid tumors	17
Issue Information	17
Cancer survivors have an increased risk of cardiovascular disease	17
Associations between birth defects with neural crest cell origins and pediatric embryonal tumors	17
Disparities in cancer genetics care by race/ethnicity among pan‐cancer patients with pathogenic germline variants	17
Issue Information	17
	17
Disparities in pancreatic cancer care and research in Native Americans: Righting a history of wrongs	17
The cost burden of metastatic prostate cancer in the US populations covered by employer‐sponsored health insurance	17
Safety and effectiveness of the radium‐223–taxane treatment sequence in patients with metastatic castration‐resistant prostate cancer in a global observational study (REASSURE)	17
American Radium Society Appropriate Use Criteria for the use of liver‐directed therapies for nonsurgical management of liver metastases: Systematic review and guidelines	17
Cancer‐related inflammation and depressive symptoms: Systematic review and meta‐analysis	17
Issue Information	17
Erratum to “Use of a clinical trial screening tool to enhance accrual”	17
Issue Information	17
Top advances of the year: Cervical cancer	17
The American Cancer Society National Lung Cancer Roundtable strategic plan: Advancing comprehensive biomarker testing in non–small cell lung cancer	16
Self‐help smoking cessation intervention for Spanish‐speaking Hispanics/Latinxs in the United States: A randomized controlled trial	16
Reply to “How should decision aids be developed, and which patient outcomes should be assessed?”	16
Delineation of features, responses, outcomes, and prognostic factors in pediatric PDGFRB‐positive acute lymphoblastic leukemia patients: A retrospective multicenter study	16
Characterization of HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study	16
Social relationships and their impact on health‐related quality of life in a long‐term breast cancer survivor cohort	16
Bariatric surgery and oral chemotherapy: Where is the dosing guidance?	16
Comparing clinical and nonclinical cancer patient navigators: A national study in the United States	16
Generalizing approaches to surveillance for complex social outcomes in broad‐range patient populations—The cost in terms of lost information and subgroup utility	16
	16
Cumulative exposure to impaired fasting glucose and gastrointestinal cancer risk: A nationwide cohort study	16
Sexual health in adult survivors of childhood cancer: A Project REACH study	16
Meta‐analysis of sex and racial subgroup participation rates and differential treatment effects for trials in solid tumor malignancies leading to US Food and Drug Administration registration between 2	16
Reply to “Vitamin D and breast cancer: Stop torturing the data!”	16
Switching the scope from “how to identify cancer survivors” to “who is participating in cancer survivorship research”: A proposal for a new focus	16
New persistent opioid use among adolescents and young adults with sarcoma	16